Recent Finacing
Recent Raise
TC BioPharm develops immunotherapies using a proprietary allogeneic gamma-delta T cell platform and is advancing a clinical-stage pipeline targeting cancer and severe viral infections.
Focus Areas
Total Raised
Funding round
See the team members at TC BioPharm.
